Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer

ConditionCarcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHôpital NOVO

About this trial

This study aims to validate a French version of the Nasal Reconstruction FACE-Q questionnaire for patients who have undergone nasal reconstruction or prosthetic rehabilitation after surgery for nasal skin cancer. The questionnaire evaluates appearance, quality of life, and possible side effects related to the reconstruction.

The investigators hypothesize that the validated French version will provide a reliable and standardized tool to assess patient satisfaction and health-related quality of life in this context.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Patient who has undergone excision of a cutaneous, mucocutaneous, or vestibular nasal cancer with surgical reconstruction using a flap or prosthetic rehabilitation, performed more than 4 months ago, with stable results, and less than 3 years ago

Patient informed of the study and not opposed to participation

Disqualifiers

Patient under anticoagulant or antiplatelet therapy Non-French-speaking patient

Patient under legal protection (e.g., guardianship, legal safeguard) or with limited legal capacity

Patient unlikely to cooperate with the study and/or poor anticipated compliance as judged by the investigator (including psychiatric disorders other than depressive disorder or cognitive impairment)

Pregnant or breastfeeding woman

Trial design

Treatments tested in this trial

  • operated patients
  • Control

Treatment groups

346 Participants
are divided into 2 treatment groups

Sponsors and collaborators